Suppr超能文献

酵母衍生物作为牛对Bm86抗原免疫反应佐剂的评估。

The evaluation of yeast derivatives as adjuvants for the immune response to the Bm86 antigen in cattle.

作者信息

Rodríguez Valle M, Montero C, Machado H, Joglar M, de la Fuente J, Garcia-Garcia J C

机构信息

Mammalian Cell Genetics Division, Centro de Ingeniería Genética y Biotecnología, P,O,Box 6162, Havana, Cuba.

出版信息

BMC Biotechnol. 2001;1:2. doi: 10.1186/1472-6750-1-2. Epub 2001 May 24.

Abstract

BACKGROUND

The Gavac vaccine against the cattle tick Boophilus microplus has proven its efficacy in a large number of controlled and field experiments. However, this vaccine could be further improved by searching for new alternative adjuvants that would induce a stronger long-lasting immune response. We conducted several experiments to assay the adjuvant effect of fractions of the recombinant yeast Pichia pastoris in mouse and cattle models. In previous experiments, the combination of the yeast membrane with saponin was the most effective formulation in stimulating the humoral immune response in mice, eliciting a response higher than Montanide 888. The response was predominantly of the IgG1 isotype. Here, we evaluated the response in cattle and compared the results with that obtained in mice.

RESULTS

Bm86 on the membrane of P. pastoris plus saponin produced high antibody titers in cattle, though the protection level against tick infestations was lower when compared to Gavac, probably due to a decrease in the IgG1/IgG2 ratio. The predictive value of the mouse model was studied through correlation analysis between the isotype levels in mice and the efficacy of formulations in cattle. Good correlation was established between the level of antibodies in mice and cattle, and between the amount of anti -Bm86 IgG1 in mice and the degree of protection in cattle.

CONCLUSION

Mouse model have the potential to predict immunogenicity and efficacy of formulations in cattle. These results also support the use of the yeast expression system for recombinant vaccine formulations, enabling the prediction of more cost--effective formulations.

摘要

背景

抗牛蜱微小牛蜱(Boophilus microplus)的加瓦克(Gavac)疫苗已在大量对照实验和田间实验中证明了其有效性。然而,通过寻找能诱导更强持久免疫反应的新型替代佐剂,这种疫苗可以得到进一步改进。我们进行了多项实验,以检测重组酵母毕赤酵母(Pichia pastoris)的组分在小鼠和牛模型中的佐剂效应。在之前的实验中,酵母膜与皂苷的组合是刺激小鼠体液免疫反应最有效的配方,引发的反应高于Montanide 888。该反应主要为IgG1同种型。在此,我们评估了牛的反应,并将结果与在小鼠中获得的结果进行了比较。

结果

毕赤酵母膜上的Bm86加上皂苷在牛体内产生了高抗体滴度,尽管与加瓦克疫苗相比,其对蜱侵袭的保护水平较低,这可能是由于IgG1/IgG2比例降低所致。通过对小鼠同种型水平与牛体内配方疗效之间的相关性分析,研究了小鼠模型的预测价值。在小鼠和牛的抗体水平之间,以及小鼠体内抗Bm86 IgG1的量与牛的保护程度之间建立了良好的相关性。

结论

小鼠模型有潜力预测牛体内配方的免疫原性和疗效。这些结果也支持将酵母表达系统用于重组疫苗配方,从而能够预测更具成本效益的配方。

相似文献

2
Adjuvant and immunostimulating properties of the recombinant Bm86 protein expressed in Pichia pastoris.
Vaccine. 1998 May-Jun;16(9-10):1053-5. doi: 10.1016/s0264-410x(97)00266-1.
5
Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick.
Vaccine. 1997 Mar;15(4):414-22. doi: 10.1016/s0264-410x(96)00192-2.

引用本文的文献

6
Metazoan Parasite Vaccines: Present Status and Future Prospects.后生动物寄生虫疫苗:现状与未来展望。
Front Cell Infect Microbiol. 2018 Mar 13;8:67. doi: 10.3389/fcimb.2018.00067. eCollection 2018.

本文引用的文献

2
Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick.
Vaccine. 1997 Mar;15(4):414-22. doi: 10.1016/s0264-410x(96)00192-2.
9
Humoral immune responses of Hereford cattle vaccinated with midgut antigens of the cattle tick, Boophilus microplus.
Parasite Immunol. 1990 Mar;12(2):141-51. doi: 10.1111/j.1365-3024.1990.tb00943.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验